IdentificationGeneric Name(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDEDrugBank Accession NumberDB07482BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


Download MOLSDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE (DB07482)× CloseWeightAverage: 212.054 Monoisotopic: 212.133222886 Chemical FormulaC9H17BN2O3SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUDipeptidyl peptidase 4Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassCarboxylic acids and derivativesSub ClassAmino acids, peptides, and analoguesDirect ParentAlpha amino acid amidesAlternative ParentsPyrrolidinecarboxamides / N-acylpyrrolidines / Tertiary carboxylic acid amides / Boronic acids / Organic metalloid salts / Dialkylamines / Azacyclic compounds / Organopnictogen compounds / Organic oxides / Monoalkylboranes / Hydrocarbon derivatives / Carbonyl compounds


 show 2 moreSubstituentsAliphatic heteromonocyclic compound / Alkylborane / Alpha-amino acid amide / Amine / Azacycle / Boronic acid / Boronic acid derivative / Carbonyl group / Carboxamide group / Hydrocarbon derivative / Monoalkylborane / N-acylpyrrolidine / Organic metalloid salt / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organic salt / Organoboron compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Pyrrolidine / Pyrrolidine carboxylic acid or derivatives / Pyrrolidine-2-carboxamide / Secondary aliphatic amine / Secondary amine / Tertiary carboxylic acid amide


 show 18 moreMolecular FrameworkAliphatic heteromonocyclic compoundsExternal DescriptorsL-proline derivative, N-acylpyrrolidine, boronic acids (CHEBI:41285) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyXSBZZZGVAIXJLD-YUMQZZPRSA-NInChIInChI=1S/C9H17BN2O3/c13-9(7-3-1-5-11-7)12-6-2-4-8(12)10(14)15/h7-8,11,14-15H,1-6H2/t7-,8-/m0/s1IUPAC Name[(2R)-1-[(2S)-pyrrolidine-2-carbonyl]pyrrolidin-2-yl]boronic acidSMILES[H][C@]1(CCCN1C(=O)[C@]1([H])CCCN1)B(O)OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound10198228PubChem Substance99443953ChemSpider8373728BindingDB50050521ChEBI41285ChEMBLCHEMBL63895ZINCZINC000169748497PDBe LigandBPRPDB Entries2ajdClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility30.2 mg/mLALOGPSlogP-0.52ALOGPSlogP-1.3ChemaxonlogS-0.85ALOGPSpKa (Strongest Acidic)8.61ChemaxonpKa (Strongest Basic)9.85ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area72.8 Å2ChemaxonRotatable Bond Count2ChemaxonRefractivity50.91 m3·mol-1ChemaxonPolarizability22.52 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterNoChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.703Blood Brain Barrier+0.7807Caco-2 permeable-0.6567P-glycoprotein substrateSubstrate0.5372P-glycoprotein inhibitor INon-inhibitor0.8954P-glycoprotein inhibitor IINon-inhibitor0.9891Renal organic cation transporterNon-inhibitor0.8368CYP450 2C9 substrateNon-substrate0.797CYP450 2D6 substrateNon-substrate0.731CYP450 3A4 substrateNon-substrate0.683CYP450 1A2 substrateNon-inhibitor0.871CYP450 2C9 inhibitorNon-inhibitor0.8726CYP450 2D6 inhibitorNon-inhibitor0.8895CYP450 2C19 inhibitorNon-inhibitor0.8048CYP450 3A4 inhibitorNon-inhibitor0.9172CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9479Ames testNon AMES toxic0.6165CarcinogenicityNon-carcinogens0.884BiodegradationNot ready biodegradable0.6683Rat acute toxicity2.1213 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9484hERG inhibition (predictor II)Non-inhibitor0.8428  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn moreBinding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)20N/AN/AA30867Ki (nM)3N/AN/AA18427


 Details


 Binding Properties1. Dipeptidyl peptidase 4KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionVirus receptor activitySpecific FunctionCell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by bindi...Gene NameDPP4Uniprot IDP27487Uniprot NameDipeptidyl peptidase 4Molecular Weight88277.935 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:22 / Updated at June 12, 2020 16:52 